Therapy Using Monoclonal Antibodies

In: Business

25 May 2013

Treatment methods can be as varied as the number of diseases. In accordance with this, there have been many kinds of medicines that have been introduced as cure. Surgical procedures are also often used to deal with more serious conditions in the human body. Among the more recent treatment methods that have been introduced is the monoclonal antibody therapy, one which is often used in treating cancer and similar diseases.

First, it helps to understand the function of an antibody, which is a type of protein created in our B-cells that attacks foreign viruses and bacteria. So it’s obvious that antibodies are essential to our overall health. A monoclonal antibody is an antibody that is an exact clone of another antibody, and these can be created in a laboratory setting and then used to create a variety of medicines.

The process called radioimmunotherapy is applied to deal with lymphomas. This process necessitates the bonding of monoclonal murine antibodies. It is important to apply radioactivity because lymphomas easily react to it. Murine antibodies are used in the process because these effectively flush out the elements in the body that are radioactive and, as a result, bring down the possibility of being affected by radioactivity.

There are scientists who are known for performing the process of bonding liposomes with monoclonal antibodies in order to create immunoliposomes. While this is said to be effective, it is still actually at the experimental phase. ADEPT is another anti-cancer monoclonal antibody treatment type which is also at the experimental phase. It is through this that monoclonal antibodies connect to the proteins. Once the attachment is made, the antibody releases enzymes that would prompt a cellular response which would lead to the eradication of the cancer cells.

Even as ADEPT treatment and immunoliposome treatment are still on the testing phase, there are already many other drugs in the market that are based on monoclonal antibodies. Such drugs have been known to be applicable in the treatment of rheumatoid arthritis since a monoclonal antibody attaches itself to a cytokine. Once this cytokine suffers an anomaly, inflammation is caused and this may lead to rheumatoid arthritis.

Another monoclonal antibody therapy is used to treat the autoimmune disease psoriasis. Adalimumab is one drug that has been created to combat this disease and it works by binding to that same TNF-a cytokine and preventing it from activating which lessens the severity of this serious skin disorder. This same drug also is used to treat Crohn’s disease, ulcerative colitis and psoriatic arthritis.

Armand Zeiders enjoys writing about biomedical research. For additional information about custom monoclonal antibody production services, or to find further information about protein sequencing service, please go to the PrimmBiotech.com website today.

Comment Form